Kura Oncology Inc (KURA) — Capital Reinvestment Ratio
Latest as of December 2025:
0.02x
Kura Oncology Inc (KURA) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($117.27 Million) in capital expenditures ($2.32 Million). See KURA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
$117.27 Million
USD
Capital Expenditures
$2.32 Million
USD
Data as of
Dec 2025
Most recent filing
Kura Oncology Inc Capital Reinvestment Ratio (2024–2024)
This chart tracks Kura Oncology Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Kura Oncology Inc (2024–2024)
Year-by-year Capital Reinvestment Ratio for Kura Oncology Inc from 2024 to 2024. For live market cap and broader valuation context, see KURA market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | $134.32 Million | $472.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow